Fishawack Health deepens key capabilities and builds an integrated delivery model under new Chief Marketing and Creative Officer
May 31, 2023 | Data, Healthcare Marketing, commercialization, digital experience, technology
Polymath marketer Ryan Mason leads the newly expanded group, and Jeffrey D. Erb has been tapped to grow the media and analytics team as Chief Media Officer.
WASHINGTON, DC, May 31, 2023—Leading global commercialization partner Fishawack Health (FH) announces the integration of key capabilities within its Marketing division to seamlessly deliver connected customer experiences built on data-driven insights. Tenured agency executive Ryan Mason has been promoted to Chief Marketing and Creative Officer and will unite creative, brand, and engagement strategy and media and analytics teams.
As part of this integrated offering, FH has selected industry veteran Jeffrey D. Erb to serve as Chief Media Officer. Erb is charged with growing the company’s media and analytics capabilities to expand specialized tools and resources in house.
“Ryan’s ability to foster and build teams across creative, brand, and engagement strategy and media and analytics disciplines makes him the perfect leader as we continue to offer stakeholder-centric and integrated solutions, seamlessly connecting strategy with execution,” said Mario Muredda, President, Marketing. “Jeff’s deep expertise in advancing media and analytics capabilities is core to helping our clients deliver personalized experiences that increase awareness, shift beliefs and behaviors, and are optimized in real time.”
Both Mason and Erb will collaborate with Chief Strategy Officer Drew Desjardins and Chief Technology Officer Geoff Thorne to provide unified subject matter experts embedded within client accounts and create seamless customer experiences across all touchpoints.
“Fishawack Health has a desire to create an environment where the entrepreneurial spirit fosters inventive and innovative programs with the scale, maturity, and capabilities of a large agency,” said Mason. “Taking on this role is a precious opportunity because it will enable us to not only implement sustainable change within the agency but also, more importantly, to deliver a unified service offering that will benefit our clients and their customers. What’s thrilling about this new integrated model that we’re building is the collection of talent with the readiness and interest within the culture that exists. These don’t often align in other companies, but we are able to do this and do it well.”
Originally trained in graphic design and economics, Mason has the unusual distinction of having held the roles of Chief Creative Officer, Chief Strategy Officer, and Chief Digital Officer. The throughline in these roles has been a pursuit to develop marketing experiences that are highly relevant, strategically sound, meaningfully motivating, and rooted in deep empathy. A testament to Mason’s abilities includes a patient engagement rare disease campaign that was recognized with a prestigious Cannes Pharma Lion award in 2021.
Erb has a track record of driving transformational change within the pharmaceutical media industry and building dynamic, culture-rich teams responsible for the development and deployment of targeted and optimized campaigns. Erb is a recognized thought leader in the healthcare industry and is the recipient of numerous industry awards, including induction into the DTC Hall of Fame by DTC Perspectives and being named to MM+M’s Health Influencer 50 list.
The integration of capabilities under the Marketing umbrella is purposeful. According to Muredda, “Our unified model enables us to tap into data and deep customer insights to develop highly relevant, content-rich experiences. Medical, strategy, creative, and media work seamlessly together to maximize the relevance of a brand and to accelerate growth for our clients.”
Mason is based in Chicago and Erb is in Philadelphia. In addition to leading Marketing colleagues, they will also collaborate with FH’s community of experts in Medical; Digital Experience Technology; Policy, Value, Evidence and Access; and Consulting across 19 global hubs.
Partnering with biopharmaceutical, medical technology, and wellness clients, Mason and Erb are excited to lead interdisciplinary teams, simplifying the complex to find meaning in the science, taking a customer-centric approach to ensure that as many patients as possible benefit from scientific breakthroughs.
About Fishawack Health
Established in 2001, Fishawack Health is a purposefully built commercialization partner for the biopharmaceutical, medical technology and wellness industries. Our 1,500+ experts combine their knowledge and expertise across our core disciplines—Medical; Marketing; Digital Experience Technology; Policy, Value, Evidence and Access; and Consulting—to create the connections that make better health happen. We partner with our clients to navigate the complex and rapidly changing healthcare ecosystem. Together, we realize the potential of strategies and solutions to bring innovation to the hands of those who can benefit from it. Visit us at www.fishawack.com and follow us on Twitter and LinkedIn.
CONTACT INFORMATION
Marita Gomez marita.gomez@fishawack.com
Lizzie Mitchell elizabeth.mitchell@fishawack.com
This content was provided by Avalere Health
Company Details
Latest Content from Avalere Health
Hepatitis (C)an’t wait: taking a de-centralized approach to cure the epidemic
Hepatitis C is a curable disease, so why are so many countries off track to achieve the World Health Organization elimination target? This World Hepatitis Day, we compare several countries’...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals how life...
Healthcare tech: the driving force behind value-based care?
In 2020, healthcare technology investment went into overdrive. We speak to Sunny Kumar, Partner at GSR Ventures, to find out how COVID‑19 has transformed the industry and whether healthcare technology...
Numbers, navigation, and narratives: digital storytelling in medical communications
Science and storytelling aren’t often seen as compatible. One is based on cold, hard facts, while the other is synonymous with improvisation and theater. However, when done well, storytelling can...
Building the hospital of the future
Senior Consultant Leah Carlisle explores the growing trend of virtual hospitals and what it takes to develop a holistic digital ecosystem centered on the ultimate patient experience.
Welcoming analytics-driven digital marketing agency closerlook to the Fishawack Health pack
Fishawack Health enhances its omnichannel capabilities with the acquisition of closerlook, a data analytics and digital native healthcare agency specializing in intelligent omnichannel marketing solutions.
The rise of the healthcare social media influencer
The consumer industry has long been leveraging the power of social media influencers with enormous success. But can the highly regulated healthcare industry achieve the same results? Daniel Brackins explores...
Vaccine hesitancy eBook
In this e-book, we answer the difficult questions around vaccine hesitancy. Our consultants and commercial experts explore the behavioural science and reveal strategies for improving uptake.
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention.
Are you ready for the digital health revolution?
In this edition of Delta magazine, we explore how rapid digitalization has transformed the care pathway and reveal how life science companies can succeed in the digital age.